Business Insider

Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA

CRANBURY, N.J., June 4, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment ...
Medindia

Palatin Technologies Presents Bremelanotide Neurobiology and Treatment Efficacy Review at World Meeting on Sexual Medicine

CRANBURY, N.J., Sept. 23, 2016 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
Business Wire

Competition and Regulatory Risk Cloud Potential for PTNs Bremelanotide, a Novel Agent in Development for Male and Female Sexual Dysfunction

DUBLIN, Ireland--(BUSINESS WIRE)--Sept. 22, 2006--Research and Markets (http://www.researchandmarkets.com/reports/c42471) has announced the addition of the new report ...
ABC News

New Drug for Lost Libido

Dec. 1, 2006 — -- What is desire? What triggers it? And how can we make it last? Some people think oysters, chocolate and ginseng -- among other mythical things --are aphrodisiacs. They are rich ...
manilatimes

PT-141 Nasal Spray Launched For Sale By Top Peptides Company

Gulf Breeze, FL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in sexual health solutions, is thrilled to announce the release of its groundbreaking PT-141 nasal spray, a ...